ReleaseWire Connect

The global market for craft beer is highly fragmented in nature, with higher presence of a number of local microbreweries, and regional craft breweries, especially across developed regions such as Europe. Craft beer industry is one of the oldest industry around the world. Major craft beer establishments are independently-owned, as they fall under small-scale industry sector. Craft beer has been witnessed to acquire higher consumer attraction, being a traditionally-produced drink, which is why consumers are willing to spend more money for craft beer. Governments in Mexico, China, the U.K, New Zealand, Belgium, and Australia, among others, have been promoting the production of craft beer, incorporating new breweries. This initiative is further expected to contribute to the beverage industry's economic development and employment generation. The global craft beer market comprises several small-sized players, with expansion and consolidation activities increasing among some large brewers in the market.

Cell lines are used in research and biologics and used in drug discovery, molecular biology, biochemistry, cell biology etc. The global cell lines market is influenced by several advantages that the cell liens offer, which include ease in use, cost effectiveness, as well as they provide pure cells which are needed to obtain reproducible results along with consistent samples. Moreover, the growing technological developments in the healthcare industry, new innovations and increased investment in the research and development has resulted in the discovering several paradigms for cell lines, thereby pushing the growth of the global cell lines market. North America region seems to be the most attractive region for the cell lines market.

According to a recently published research by Fact.MR, the global veterinary imaging systems market is projected to expand at an impressive CAGR during the forecast period 2017 to 2022. Sales of veterinary imaging systems will account for over US$ 2,000 Mn revenues by 2022-end.

Growing prevalence of medical diseases and infections is projected to rev up demand for vaccine devices in the healthcare sector. Manufacturers are increasingly witnessing demand for vaccine delivery devices due to increase in number of diabetic patients globally. Fact.MR has recently compiled a report, which reveals that the vaccine delivery devices market globally is projected to reflect an impressive CAGR over the forecast period, 2017 – 2022.

A recent research by Fact.MR estimates the global gas chromatography market to exhibit an above-average expansion through the forecast period 2017 to 2022. The global market for gas chromatography is expected to exceed US$ 3,500 Mn in revenues by 2022-end.

Increasing prevalence of medical conditions has led to an upsurge in demand for surgeries in the healthcare sector. Growing need for minimally invasive surgeries is projected to impact the global growth operating room equipment market positively. Fact.MR has recently compiled a report, which states that the global market of operating room equipment is projected to register an impressive CAGR over the forecast period, 2017 – 2022.

Therapeutic peptides are used to treat various types of cardiovascular diseases. Initially, the development of peptides as therapeutic agents was avoided by the pharmaceutical industry due to their low stability, rate of degradation and poor delivery. However, in the present times, with increasing amounts of economic resources being diverted to healthcare R&D, new avenues have opened up for peptide therapeutics. Increasing healthcare expenditure and increasing FDI in emerging economies along with the emergence of prominent pharmaceutical and biotech companies is fuelling market growth in peptide therapeutics. Besides, growing number of people suffering from cardiovascular diseases is also fuelling the market for peptide therapeutics. Breakthroughs in the development of therapeutic peptides for treating cardiovascular diseases and the development of new peptides is also fuelling the market growth. However, various factors such as increasing cost of developing peptides, rapid metabolism of peptide drugs and a stringent regulatory framework may restrain the growth of therapeutic peptides.

Peptide based haematological disorders therapeutics market is exhibiting robust growth. This is due to the fact that technology for the manufacturing of peptides is rapidly evolving, with manufacturers and suppliers exploring new methods for the manufacturing of peptides. This has a positive effect on the peptide therapeutics market and leads to the formation of longer and complex chain of peptides and reduced cost of production. In addition, due to the emergence of automated instruments, there have been improvements in the purification process of peptides and reduction in the total waste generated. These are the factors driving the growth of the peptide therapeutics market worldwide. On the other hand, the synthesis and the purification of long peptides is difficult for manufacturers. In addition, the rise in modifications and the addition of more number of unnatural amino acids have made the process of peptide synthesis complex. This makes the manufacturing of peptides difficult, and hence the gap between demand and supply is increasing and the cost of manufacturing of peptides is also accelerating, thereby hampering market growth.

Drug makers are increasingly partnering with medical research centers and institutes to develop more effective peptide drugs. This, in turn, is projected to make a positively impact on the growth of the global peptide based gastrointestinal disorders therapeutics market in the near future. A recent study conducted by Fact.MR reveals that the global market for peptide based gastrointestinal disorders therapeutics is poised to exhibit a strong CAGR during the forecast period (2017-2022), to reach a valuation in excess of US$ 600 Mn. Growing occurrence of metabolic disorders and gastrointestinal ailments related to the digestive system is compelling physicians to utilize novel therapeutic drugs that are more efficient than the traditional ones. In addition, incessant structural improvements in peptide synthesis coupled with development of high-throughput approaches and hybrid mixing of solid and liquid synthesis is partly responsible for the exciting preclinical results shown by new peptide drugs for treating a number of gastrointestinal diseases. Drug makers are also emphasising on enhancing peptide properties, such as stability and half-life to overcome few of the limitations of peptides. In recent years, a lot of progress has been made in developing efficacious peptide therapeutics. Nonetheless, the high complexity of peptides remain a major challenge for manufacturers and hence dampening the surging spirit of the market to a certain extent.

North America shows higher market attractiveness; this growth mainly attributed to the higher investment in the healthcare industry along with rapid technological developments.